About Nob Hill Therapeutics
Nob Hill Therapeutics is a private company based in Albuquerque, New Mexico. It has reported $668,545 raised in five offerings on Form D since November 2016. Its chief executive is Yun Li.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 23, 2021 | Jun 29, 2021amended Sep 20, 2021 | $150,000of $600K target | 2 | $75,000 | OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Apr 9, 2021 | Apr 12, 2021 | $50,000of $200K target | 1 | $50,000 | OptionsRule 506(b) | Form D ↗ |
| Nov 15, 2019 | Nov 18, 2019 | $75,000of $500K target | 1 | $75,000 | EquityRule 506(b) | Form D ↗ |
| Nov 6, 2018 | Nov 15, 2018 | $143,545of $400K target | 1 | $143K | Equity, DebtRule 506(b) | Form D ↗ |
| Nov 1, 2016 | Nov 15, 2016amended Apr 25, 2018 | $250,000fully sold | 1 | $250K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, five offerings | $668,545 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Nob Hill Therapeutics's Form D filed Sep 20, 2021.
Earlier filings also listed Noel Greenberger (chief executive officer and director, last listed Aug 2024), Chris Japp (director, last listed Aug 2024), R. Goforth (director, last listed Nov 2018), Mark Kidd (executive officer, last listed Apr 2018) and Jee Shin (chief executive officer and director, last listed Apr 2018).